Spectrum Pharmaceuticals reported $0 in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 84.36M 6.68M
Amgen AMGN:US $ 4115M 98M
Arrowhead Research ARWR:US 0 0
Astellas Pharma 4503:JP Y 157254M 6826M
Bayer BAYN:GR € 10125M 332M
Biogen BIIB:US $ 1254.8M 83M
Bristol Myers Squibb BMY:US $ 2137M 184M
Coherus Biosciences CHRS:US $ 96.08M 44.47M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Endo International Ordinary Shares ENDP:US $ 338.46M 23.72M
GlaxoSmithKline GSK:LN 6330M 114M
Karyopharm Therapeutics KPTI:US $ 3.9M 791K
Novartis NOVN:VX SF 7111M 114M
Puma Biotechnology PBYI:US $ 7.62M 0.12M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 4.36B 44M
YTE INCY:US $ 16.68M 0.02M